Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/1995
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2146701A1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/11/1995EP0676398A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/10/1995US5457209 4-[α(cyanophenyl)-1-(1,2,3-triazolyl)methyl]-benzonitrile
10/10/1995US5457109 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
10/04/1995EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen
10/04/1995EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen
10/03/1995CA2065093C Remedies for bone diseases
09/1995
09/29/1995CA2145584A1 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
09/29/1995CA2145579A1 Eva-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
09/28/1995WO1995025522A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
09/27/1995EP0673254A1 6-position modified decapeptide lhrh antagonists
09/27/1995EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
09/27/1995EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases
09/27/1995CN1108929A Sugar-coated pharmaceutical dosage unit
09/26/1995US5453488 Amino-substituted heterocycles as renin inhibitors
09/20/1995EP0672037A1 1,4-benzodiazepine derivatives and their use as cck-modulators
09/14/1995WO1995024211A1 Use of fibroblast growth factors to stimulate bone growth
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995CN1108255A Methods of inhibiting the symtoms of premenstrual syndrome/late luteal phase dysphoric disorder
09/13/1995CN1108098A Methods of inhibiting alzheimer's disease
09/12/1995US5449522 Antitumor
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/06/1995EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
09/06/1995EP0669934A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained
09/06/1995EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
08/1995
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/30/1995CN1029615C Novel 2,6-Di-alkyl-4-silyl-phenols as antiatherosclerotic agents
08/30/1995CN1029614C Bis-|4-(2,6-di-alkyl) phenol¨ silane derivatives as antiathe-rosclerotic agents
08/29/1995US5446036 13-alkyl-11beta-phenylgonanes
08/29/1995US5445832 Composition of sustained and controlled release of medicamentous peptide substances by converting water soluble peptide into a water insoluble peptide salt
08/24/1995WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems
08/24/1995WO1995022321A1 Desogestrel-containing transdermal application agent
08/24/1995DE4405899A1 Mittel zur transdermalen Applikation enthaltend Desogestrel Means for transdermal administration comprising desogestrel
08/24/1995DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids
08/24/1995CA2183544A1 Desogestrel-containing transdermal application agent
08/23/1995EP0667856A1 Novel vitamin d analogues
08/23/1995EP0510167B1 Novel steroidal organic substance crystallization method and compounds thereby obtained
08/23/1995CN1107157A Methods for the treatment of peri-menopausal syndrome
08/17/1995WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/16/1995EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666746A1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS
08/16/1995CN1106691A Medicine for regulating endocrine function of woman
08/10/1995WO1995020972A1 Treatment of ovarian estrogen dependent conditions
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665748A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665747A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995EP0659179A4 Benzo-fused lactams promote release of growth hormone.
08/08/1995US5440012 Excellent blood calcium-decreasing activity and chondrocyte differentiating-promoting activity
08/08/1995US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator
08/08/1995CA1336579C Delivery systems for the controlled administration of lhrh analogs
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995CA2182205A1 Human growth hormone
08/02/1995EP0664811A1 Gestagenically active 19,11-bridged 4-estrenes.
08/02/1995CN1106005A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives
08/02/1995CN1106004A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
08/02/1995CN1105860A 碘酸钾制剂 Preparation of potassium iodate
08/01/1995US5438136 Benzo-fused macrocycles promote release of growth hormone
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
07/1995
07/27/1995WO1995019785A1 Treatment for juvenile diabetes
07/26/1995EP0416037B1 Superoxide dismutase analogs having novel binding properties
07/25/1995US5436401 Skin disorders
07/19/1995EP0662977A1 NOVEL 17$g(b)-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
07/19/1995EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
07/18/1995US5434138 Gonadoliberin antagonists
07/13/1995WO1995018625A1 The composition containing snapping turtle and tortoise, the preparation and the use thereof
07/13/1995WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof
07/12/1995EP0662481A1 Spiro piperidines and homologs promote release of growth hormone
07/04/1995US5430144 E.g, N-(1-((2'-((methoxycarbonyl)amino)(1,1'-biphenyl)-4-yl) methyl)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-3-yl)-3 ((fur-2-yl)methyl)amino-3-methylbutanamide
07/04/1995US5430060 Aldose reductase inhibitor
06/1995
06/29/1995WO1995017423A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017422A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017170A1 Accelerated release composition containing bromocriptine
06/29/1995CA2179598A1 Compounds with growth hormone releasing properties
06/29/1995CA2179597A1 Compounds with growth hormone releasing properties
06/28/1995EP0659432A1 Sugar-coated pharmaceutical dosage unit
06/28/1995EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease
06/28/1995EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/28/1995EP0659179A1 Benzo-fused lactams promote release of growth hormone
06/22/1995WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
06/22/1995CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity
06/22/1995CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/22/1995CA2138495A1 Methods of inhibiting alzheimer's disease
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995US5426102 Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties
06/15/1995WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof
06/15/1995WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
06/15/1995WO1995015767A1 Long-acting injection suspensions and a process for their preparation
06/14/1995EP0657167A2 Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 290